Needham raises AtriCure target price to $70 from $64
ATRC•Needham raised its target price for AtriCure to $70 from $64.
Related News
JD.com plans third-quarter results conference call
JD•
DuPont: Barclays raises target price to $176 from $156
DD•
Teladoc Health: Barclays raises target price to $9 from $7
TDOC•
Crescent Energy Company: JP Morgan raises target price to $23 from $21
CRGY•
Waters Corporation: Barclays raises target price to $530 from $500
WAT•